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OBJECTIVES: 
Primary objective: To observe the effect of enteral immunomodulating nutrition on 
length of hospital stay in a patient with esophageal carcinoma undergoing surgery. 
Secondary Objective: To observe the incidence of post-operative complications, 
namely pneumonia, surgical wound infection and anastomotic leak. 
METHODS: 
Prospective interventional study with retrospective controls, approved by the 
Institutional Review Board with financial grant for the same. Total of 43 patients with 
esophageal carcinoma who were planned for elective surgery were included in the 
study (21 cases and 22 controls). The cases were started on an immune enhancing 
supplement in form of Glutamine powder at a dose of 0.3gms/kg/day four days prior 
to surgery and were continued on the same post-operatively for a period of two weeks. 
The total number of days of hospital stay and the incidence of post-operative 
complications (pneumonia, wound infection and anastomotic leak) were compared 




 RESULTS:  
 
43 patients who had esophageal carcinoma and who were planned for elective 
esophagectomy were studies (21 cases and 22 controls). The cases were patients who 
underwent elective esophagectomy between April, 2015 and August, 2016. These 
patients received immune enhancing supplement in form of glutamine. The controls 
were patient with esophageal carcinoma who underwent elective esophagectomy 
between January, 2013 and December, 2014. These patients had not received immune 
enhancing supplements. Statistical test used to compare the total number of days of 
hospital stay between the two groups was Mann Whitney U test. The p value obtained 
when comparing the groups of individuals who got immunonutrition and those who 
did not receive the same was 0.004 which was statistically significant. This meant that 
the patients who got immunonutrition should stay in the hospital less than those who 
did not. When we compare the ICU stay of these two groups, there was no significant 
difference (p=0.295).  
The incidence of post-operative pneumonia among the groups were also compared, 
even if there was difference in proportions(10% v/s 32%), this was not statistically 
significant (p=0.132). In the case of post-operative wound infection, the groups were 
not different(p>0.999). Anastomotic leak was less among immunonutrition group, 
however it was not statistically significant at 5% alpha level. The incidence rates were 
compared using Fishers exact test in this study. There were no serious side-effects 
associated with administration of Glutamine powder. 
 
 CONCLUSION: 
Peri-operative Immunonutrition may be safe and effective in reducing the total length 
of hospital stay in patients with esophageal carcinoma undergoing elective 
esophagectomy as compared to standard nutrition. However, further large randomized 
control trials are required to further prove the efficacy of glutamine in patients with 
esophageal carcinoma undergoing elective surgery.  
 
 
 
 
 
